Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. (PRAX) is a publicly traded company in the Unknown sector. Across all available filings, 22 corporate insiders have executed 149 transactions totaling $62.3M, demonstrating a bearish sentiment with -$51.6M in net insider flow. The most recent transaction on Jan 12, 2026 involved a transaction of 943 shares valued at $260.0K.
PRAX Insider Activity Summary
Who Is Buying PRAX Stock?
No significant insider buying has been recorded for PRAX in the recent period.
Who Is Selling PRAX Stock?
No significant insider selling has been recorded for PRAX in the recent period.
Is Praxis Precision Medicines, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for PRAX is bearish with an Insider Alignment Score of 9/100 and a net flow of -$51.6M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
PRAX Frequently Asked Questions
Understanding PRAX Insider Activity
Insider trading at Praxis Precision Medicines, Inc. (PRAX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 22 insiders are actively trading PRAX stock, having executed 149 transactions in the past 90 days. The most active insider is Phillip Gross (Executive), who has made 10 transactions totaling $33.2M.
Related Tools
Track Praxis Precision Medicines, Inc. Insider Activity
Get notified when executives and directors at PRAX file new Form 4 transactions